The mechanism of action and neuromodulation principles of Stiripentol

Stiripentol (Stiripentol) is an anti-epilepsy drug commonly used to treat refractory epilepsy, especially in patients with Dravet syndrome. Its mechanism of action is relatively complex. It mainly modulates the nervous system by enhancing GABAergic nerve conduction and inhibiting the activity of NMDA (N-methyl-D-aspartate) receptors, thereby achieving the effect of controlling epileptic seizures.

GABA (gamma-aminobutyric acid) is an inhibitory neurotransmitter that normally plays an important inhibitory role in the brain and spinal cord. Stipentol can increase the effect of GABA, thereby enhancing inhibitory transmission in the nervous system. This means it helps suppress excessive electrical activity between neurons, which is critical in reducing epileptic seizures. Stipentol helps balance the excitation and inhibition of neurons by improving the function of GABA, thereby reducing epileptic seizures caused by over-excitation of neurons.

In addition, stiripentol also inhibits the activity of NMDA receptors. NMDA Receptor is one of the main receptors for the excitatory neurotransmitter glutamate, which plays an important role in learning, memory and neuroplasticity. However, overactivation of NMDA receptors may lead to excessive excitability of neurons, thereby inducing epileptic seizures. Stipentol further reduces nerve excitability and helps stabilize the nervous system by inhibiting NMDA receptors.

In addition, stiripentol also helps regulate the flow of calcium ions and affects intracellular signaling pathways, which also plays a role in controlling epileptic seizures. It helps reduce abnormal discharges in the cerebral cortex through multiple mechanisms, thereby alleviating the symptoms of epilepsy patients.

In summary, stiripentol affects the nervous system through multiple pathways, especially by enhancing the inhibitory effect of GABA and inhibiting NMDA receptor activity. Through these mechanisms, stiripentol can effectively control epileptic seizures and improve patients' quality of life.

Reference materials: https://www.diacomit.com/